ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Jiazhang Xing
Matched on ORCID iD 0000-0002-5430-5497; OpenAlex author ID A5070145201. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2019: 1 paper · 2020: none · 2021: 1 paper
Papers 2
- Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resecti… Co-author DOI 10.3389/fonc.2021.660215↗
- CA19-9 elevation as an indication to start salvage treatment in surveillance after pancreatic cancer resection. Co-author DOI 10.1016/j.pan.2019.01.023↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuejuan Cheng · 2 shared papers, 2019–2021 · strength 0.24
- Paper Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients … DOI 10.3389/fonc.2021.660215↗
- Paper CA19-9 elevation as an indication to start salvage treatment in surveillance after pancreatic cancer resection. DOI 10.1016/j.pan.2019.01.023↗
- Chunmei Bai · 2 shared papers, 2019–2021 · strength 0.24
- Paper Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients … DOI 10.3389/fonc.2021.660215↗
- Paper CA19-9 elevation as an indication to start salvage treatment in surveillance after pancreatic cancer resection. DOI 10.1016/j.pan.2019.01.023↗
- Jiarui Li · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.